English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Osteosarcoma is a rare but serious sequel of radiotherapy.1 The incidence of sarcomas post-irradiation therapy comprises about 0.1% of all cancer cases and the sarcomas usually appear 10 to 14.3 years post-treatment.1,2 Women are expected to suffer these sequels because they are more frequently subjected to radiotherapy for breast and gynecological cancers and they have better long-term survival.2 Here, the difficulties of clinical management will be briefly addressed and also some issues in the literature on this field will be discussed.

Sacrum osteosarcoma after pelvic radiation for uterine cervical cancer: highlighted issues